1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood conditions

Subcutaneous efgartigmod with recombinant human hyaluronidase PH20 for treating primary immune thrombocytopenia TS ID 11977

Awaiting development [GID-TA11507] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 30972-Efgartigimod-PH20-SC-for-Immune-Thrombocytopenia-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)